Results 131 to 140 of about 2,904,132 (380)

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Survey of the Burn Wound Healing by Iranian Traditional Medicine from the Herbalists or Herbal Medicine Vendors in the Mazandaran Province

open access: yesJournal of Medicinal Plants, 2013
Background: A Burn injury is a major health problem in the developing countries. Various treatments were applied for treatment of burn wounds by Iranian traditional medicine for thousands of years ago. Objective: The purpose of this study was to evaluate
E Nasiri   +3 more
doaj  

Online eurythmy therapy for cancer-related fatigue: a prospective repeated-measures observational study exploring fatigue, stress, and mindfulness

open access: yesFrontiers in Integrative Neuroscience
IntroductionCancer is a debilitating disease with an often chronic course. One of the most taxing and prevalent sequelae in this context is cancer-related fatigue (CRF) resulting from the disease and/or associated treatments.
Eliane Timm   +4 more
doaj   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Recommended natural products in Alzheimer\'s disease based on traditional Persian medicine

open access: yesJournal of Medicinal Plants, 2020
Background: Alzheimerchr('39')s disease is the most common cause of dementia, especially in elderlies. Its exact pathogenesis is not yet known and existing therapies do not have enough efficacy.
Amir Hossein Jamshidi   +5 more
doaj  

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

The medical perspective of cupping therapy: Effects and mechanisms of action

open access: yesJournal of Traditional and Complementary Medicine, 2019
Cupping Therapy (CT) is an ancient method and currently used in the treatment of a broad range of medical conditions. Nonetheless the mechanism of action of (CT) is not fully understood. This review aimed to identify possible mechanisms of action of (CT)
Abdullah M.N. Al-Bedah   +8 more
doaj  

AI and Medicine [PDF]

open access: yesarXiv, 2019
Which part of medicine, if any, can and should be entrusted to AI, now or at some moment in the future? That both medicine and AI will continue to change goes without saying.
arxiv  

Opportunities at the interface of network science and metabolic modelling [PDF]

open access: yesarXiv, 2020
Metabolism plays a central role in cell physiology because it provides the molecular machinery for growth. At the genome-scale, metabolism is made up of thousands of reactions interacting with one another. Untangling this complexity is key to understand how cells respond to genetic, environmental, or therapeutic perturbations. Here we discuss the roles
arxiv  

On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study

open access: yesMolecular Oncology, EarlyView.
The LEXOVE prospective study evaluated plasma cell‐free extracellular vesicle (cfEV) dynamics using Bradford assay and dynamic light scattering in metastatic non‐small cell lung cancer patients undergoing first‐line treatments, correlating a ∆cfEV < 20% with improved median progression‐free survival in responders versus non‐responders.
Valerio Gristina   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy